🔎 Trials Near Me

Home › Pancreatic Cancer › California

Pancreatic Cancer clinical trials in California

91 studies for Pancreatic Cancer are looking for participants at sites in California.

Cities in California

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • and 10 more
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • City of Hope National Medical Center, Duarte
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06465069

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • City of Hope, Duarte
  • University of California San Diego, San Diego
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07562152

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

  • City of Hope Duarte, Duarte
  • University of California at Los Angeles, Santa Monica
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07529808

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • City of Hope at Irvine Lennar, Irvine
  • and 2 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05372614

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • City of Hope, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  • City of Hope National Medical Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • and 3 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07090499

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Los Angeles
  • PHN-012-001 Site, San Diego
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07127874

Pancreatic Cancer Detection Consortium

  • City of Hope Medical Center, Monrovia
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06388967

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • City of Hope Cancer Center-Duarte, Duarte
  • Providence Medical Foundation, Santa Rosa
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277413

DESTINY-PANTUMOUR04

  • Research Site, San Diego
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • University of California San Diego, La Jolla
  • Stanford University, Palo Alto
  • UCLA Medical Center, Santa Monica
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04981119

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • UC San Diego Medical Center - Encinitas, Encinitas
  • Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UCI Health - Irvine, Irvine
  • and 14 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07229313

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

  • UC San Diego Moores Cancer Center, La Jolla
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles, Los Angeles
  • and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07252232

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • UC IRVINE Health, Orange
  • UC Davis Comprehensive Cancer Center, Sacramento
  • Stanford Cancer Institute, Stanford
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

UCSF PANC Cyst Registry

  • University of California, San Francisco, San Francisco
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04291651

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  • Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton, Fullerton
  • UCI Health - Irvine, Irvine
  • Cedars-Sinai - Cedars-Sinai Medical Center, Los Angeles
  • and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07409272

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • UC San Diego Moores Cancer Center, La Jolla
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
  • UCLA Hematology/Oncology- Santa Monica, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US051, Duarte
  • Investigative Site US085, Fullerton
  • Investigative Site US054, La Jolla
  • and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07522073

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

  • University of California, San Francisco, San Francisco
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT06271291

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0096, San Francisco
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07492680

CREO - Microwave Ablation Feasibility Study

  • Cedars Sinai, Los Angeles
Recruiting
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07817147

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

  • Children's Hospital Los Angeles, Los Angeles
  • Cedars Sinai Medical Center, Los Angeles
  • UCSF Benioff Children's Hospital Oakland, Oakland
  • and 1 more
RecruitingObservational study
Up to age 17 · All sexes · Updated Sep 11, 2026 · NCT06651580

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

  • City of Hope, Duarte
Recruiting
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT05764720

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • USC/Norris Comprehensive Cancer Center, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06440005

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06400472

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
  • UC San Diego Moores Cancer Center, La Jolla
  • Loma Linda University Medical Center, Loma Linda
  • and 5 more
RecruitingObservational study
Ages 50 to 75 · All sexes · Updated Sep 4, 2026 · NCT04239573

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT05687123

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  • START- Los Angeles, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • Valkyrie Clinical Trials, Los Angeles
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07644559

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

  • Hoag Memorial Hospital Presbyterian, Newport Beach
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06673017

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Kaiser Permanente-Division of Research, Pleasanton
RecruitingHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated Sep 2, 2026 · NCT06995898

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • City of Hope at Irvine Lennar, Irvine
  • and 2 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT04172532

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Recruiting
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT05497531

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • University of Southern California, Los Angeles
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
  • Cedars-Sanai Medical Center, Los Angeles
  • and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06582017

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

  • Cedars-Sinai, Los Angeles
Recruiting
Ages 18 to 120 · All sexes · Updated Aug 27, 2026 · NCT06698458

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • Alta Bates Summit Medical Center-Herrick Campus, Berkeley
  • and 20 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06958328

Understanding New Cachexia Subtypes Through Observational Epidemiological Research

  • Kaiser Permanente Northern California, Pleasanton
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07776353

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07619313

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.